> Detailanzeige

Hessmann, Philipp [VerfasserIn]; Zeidler, Jan [VerfasserIn]; Stahmeyer, Jona [VerfasserIn]; Eberhard, Sveja [VerfasserIn]; Vogelgsang, Jonathan [VerfasserIn]; Abdel-Hamid, Mona [VerfasserIn]; Wolff-Menzler, Claus [VerfasserIn]; Wiltfang, Jens [VerfasserIn]; Kis, Bernhard [VerfasserIn]

Claims data analysis on the dispensing of tricyclic antidepressants among patients with dementia in Germany - [published Version]

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel; Sonstige Veröffentlichung
  • Titel: Claims data analysis on the dispensing of tricyclic antidepressants among patients with dementia in Germany
  • Beteiligte: Hessmann, Philipp [VerfasserIn]; Zeidler, Jan [VerfasserIn]; Stahmeyer, Jona [VerfasserIn]; Eberhard, Sveja [VerfasserIn]; Vogelgsang, Jonathan [VerfasserIn]; Abdel-Hamid, Mona [VerfasserIn]; Wolff-Menzler, Claus [VerfasserIn]; Wiltfang, Jens [VerfasserIn]; Kis, Bernhard [VerfasserIn]
  • Erschienen: Lausanne : Frontiers Media S.A., 2019
  • Erschienen in: Frontiers in Pharmacology 10 (2019)
  • Ausgabe: published Version
  • Sprache: Englisch
  • DOI: https://doi.org/10.15488/5221; https://doi.org/10.3389/fphar.2019.00841
  • ISSN: 1663-9812
  • Schlagwörter: Claims data ; Tricyclic ; Pharmacotherapy ; Dementia ; Antidepressants
  • Entstehung:
  • Anmerkungen: Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
  • Beschreibung: Objective: A restrictive use of tricyclic antidepressants (TCA) in patients with dementia (PwD) is recommended due to the hazard of anticholinergic side effects. We evaluated the frequency of TCA dispensing in PwD over a period of 1 year and the use of TCA before and after the incident diagnosis of dementia. Methods: This analysis was based on administrative data from a German statutory health insurance for a period of 2 years. Totally, 20,357 patients with an incident diagnosis of dementia in 2014 were included. We evaluated the dispensing of TCA in 2015. Subgroup analyses were conducted to evaluate associations between the incident diagnosis of dementia and modifications in TCA dispensing. Results: In 2015, 1,125 dementia patients (5.5%) were treated with TCA and 31% were medicated with TCA in all four quarters of 2015. Most dispensings were conducted by general practitioners (67.9%). On average, patients received 3.7 ± 2.6 dispensings per year. Amitriptyline (56.3%), doxepin (26.8%), and trimipramine (16.8%) were dispensed most often. Subgroup analyses revealed that the dispensing of TCA remained mainly unchanged following the incident diagnosis. Conclusion: A relevant number of PwD were treated with TCA. To maintain the patients' safety, an improved implementation of guidelines for the pharmaceutical treatment of PwD in healthcare institutions might be required. Since 68% of the patients suffered from depression, future studies should further evaluate the indications for TCA. Copyright © 2019 Hessmann, Zeidler, Stahmeyer, Eberhard, Vogelgsang, Abdel-Hamid, Wolff-Menzler, Wiltfang and Kis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not ...
  • Zugangsstatus: Freier Zugang
  • Rechte-/Nutzungshinweise: Namensnennung (CC BY)